Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. - Wikidata - wikimedia - TriplyDB

Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

http://www.wikidata.org/entity/Q35666523

about

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China Genotypic analysis of Klebsiella pneumoniae isolates in a Beijing Hospital reveals high genetic diversity and clonal population structure of drug-resistant isolates Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin.Molecular characterization of Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in Ontario, Canada, 2008-2011.OXA-48-producing Enterobacteriaceae causing bacteremia, United Arab Emirates Fecal carriage of carbapenemase-producing Enterobacteriaceae: a hidden reservoir in hospitalized and nonhospitalized patients.Multidrug-resistant (MDR) Klebsiella pneumoniae clinical isolates: a zone of high heterogeneity (HHZ) as a tool for epidemiological studies Molecular epidemiology of colonizing and disease-causing Klebsiella pneumoniae in paediatric patients.Outbreak of a cluster with epidemic behavior due to Serratia marcescens after colistin administration in a hospital setting Carbapenemase-producing enterobacteriaceae in Spain in 2012.Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective.Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options.Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections.Faecal carriage of carbapenemase-producing Gram-negative bacilli in hospital settings in southern France.Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study.Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.Exploring the Genome and Phenotype of Multi-Drug Resistant Klebsiella pneumoniae of Clinical Origin.Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review.A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.French regional surveillance program of carbapenemase-producing Gram-negative bacilli: results from a 2-year period.Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain: Table 1

P2860

Q26764796-8BEEA88A-3594-4DCA-BF57-2B5FBF3523CA Q28076260-E2EF4786-4A71-49C4-BDE3-8FEAECD7DF04 Q28481714-685C992A-6028-4E51-904B-F1B6C811D9F8 Q28486369-3F063F07-AD71-4D74-B19C-42D4A2C56E0F Q30235041-D72FD9A6-5D4C-4543-970F-A944D2AB6840 Q30249131-B5A81088-47A0-4879-B250-A87AF8F98344 Q34790455-B8B38AC3-92EF-4ECE-83C7-B12D11E63CAE Q34982942-CD66EDBC-599D-4964-839E-A75047F9DC3F Q35942957-B6441341-CF97-4730-8DD1-953E6FDDD61D Q36040776-F4D5403B-CA31-46A6-8520-2D1D8DD48ABC Q36739334-94242C55-145F-4967-8351-3595EF7923C1 Q36971226-D764C50C-1FCF-4730-A999-CB65DFF3CE6F Q37335683-E4602D4A-A1D1-48FA-B56F-FA9FDF57156C Q38068604-29D2E146-4D62-41B6-B890-6E3892A17A26 Q38147851-AF4763BE-6CD0-46A4-93B5-0DADE42559D5 Q38392082-F7C4EF98-7ECD-4A7D-8EEB-283EB69E0D2A Q40494723-8BD75BCB-2243-415C-AF92-0748B95C25B5 Q41586909-F07D1523-E18D-4DDB-A947-A184CACD7728 Q41846236-9E54F638-77FA-4E20-83C4-D34891AE307F Q43409405-0988F713-1509-4F70-9475-674D5ACB57B5 Q44800276-24EE2933-1F86-4CAA-AC63-57BBDB4B690B Q47139448-7939FDA3-858A-485B-A655-761DB87E4D5F Q50077304-ED7B1C88-2BD7-48FE-93C8-6E4DD3C7BEDE Q53086834-3786ED98-1E53-4778-ACF3-5979AE358A75 Q57657302-422BC447-54F2-4AFD-9010-E52C86582220

P2860

Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

http://www.wikidata.org/entity/Q35666523

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Nosocomial outbreak of VIM-1-p ...... cal risk factors, and outcome.

@ast

Nosocomial outbreak of VIM-1-p ...... cal risk factors, and outcome.

@en

type

label

Nosocomial outbreak of VIM-1-p ...... cal risk factors, and outcome.

@ast

Nosocomial outbreak of VIM-1-p ...... cal risk factors, and outcome.

@en

prefLabel

Nosocomial outbreak of VIM-1-p ...... cal risk factors, and outcome.

@ast

Nosocomial outbreak of VIM-1-p ...... cal risk factors, and outcome.

@en

P1433

Q35666523-B3AECDA5-CE6C-49CC-9B1F-7FC88E545BDD

P1476

Q35666523-3900B2AE-75C5-4887-A819-C5FE08A9D834

P2093

Q35666523-149D245D-68BD-4F6A-A6E2-6A9DE576F224

Q35666523-194A8B15-FA09-41BC-B97B-EF495DEB18F3

Q35666523-30D52C28-3790-41D1-869F-998D5B0E2579

Q35666523-3BAF600D-2772-4236-85B0-1285D185FA4C

Q35666523-419C1AA6-8448-4D74-8155-7875501B0B17

Q35666523-5D4765C5-CDFD-40BF-AA93-D8A99F01D236

Q35666523-7D17C23B-9E33-40FF-83AD-5A381188E1B6

Q35666523-80E52DE4-8F07-4816-BF00-B8BBDC15E8E0

Q35666523-954DB778-BD4A-4190-938E-E9C7BCA4B052

Q35666523-D0D22F65-3780-4AD0-81B5-6AB0C86F54BE

P2860

Q35666523-143571E3-B86E-40DC-9FE3-88314A5ED4C7

Q35666523-1B910D65-6B56-45D3-A74D-A8702C2B2992

Q35666523-232D192B-3021-4C4C-8C47-58CB403F8DE2

Q35666523-25D4B4D7-DF1F-43BF-8312-8B5062F5D244

Q35666523-2E989BA2-1787-4337-B86C-02704F1600F2

Q35666523-3646D20C-8724-4101-BD35-C2D4A361D337

Q35666523-51F8F166-7BDA-4592-A8A2-6C8C6D06D925

Q35666523-58B150FA-B250-47A2-B233-B0938F8F162A

Q35666523-5D84B179-402C-4DD4-860A-8F48476B9EB1

Q35666523-5E7AEAE3-93BD-4DCF-9F75-F1A6CA310DCA

P304

Q35666523-229DAD08-04B7-4E83-9AEB-1298530D5C34

P31

Q35666523-BF1A0E10-8521-4FC1-BCB7-5BF95D137AF2

P356

Q35666523-114432FF-D00B-4370-9DF7-F03E67112653

P407

Q35666523-EFB675CD-4AC2-41D1-ABDD-BA426524FC20

P433

Q35666523-294568BE-6E2B-46FE-BCFC-FFE71B61EE12

P478

Q35666523-0B650BC0-388C-4089-9249-4FC25DE46FB6

P50

Q35666523-0120B50C-C6AA-4A03-854F-C0739E669712

Q35666523-4B300943-3BF0-45FA-9AD9-246139972A41

P577

Q35666523-A71242B1-0BD3-4893-9780-0F34237FE795

P698

Q35666523-14299519-74DB-46BA-ADF6-F76F10E02F77

P921

Q35666523-2CF16972-6924-4E5A-B970-C32F6FEB59E8

P932

Q35666523-72C7B4D2-E49A-4A2F-8CD7-0429EF4DCE00

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Nosocomial outbreak of VIM-1-p ...... ical risk factors, and outcome

@en

P2093

Ana Vindel

http://www.w3.org/2001/XMLSchema#string

Angel Asensio

http://www.w3.org/2001/XMLSchema#string

Beatriz Isidoro

http://www.w3.org/2001/XMLSchema#string

Bárbara Balandín-Moreno

http://www.w3.org/2001/XMLSchema#string

David Sáez

http://www.w3.org/2001/XMLSchema#string

Isabel Sánchez-Romero

http://www.w3.org/2001/XMLSchema#string

José Alvarez-Avello

http://www.w3.org/2001/XMLSchema#string

José Campos

http://www.w3.org/2001/XMLSchema#string

Luisa Azañedo

http://www.w3.org/2001/XMLSchema#string

María Muñoz-Algarra

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

APACHE II: a severity of disease classification system

Metallo-beta-lactamases: the quiet before the storm?

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues.

Replicon typing of plasmids encoding resistance to newer beta-lactams

Metallo-beta-lactamases: novel weaponry for antibiotic resistance in bacteria.

Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.

Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.

Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.

Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.

P304

420-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.05036-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22005997

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

P932

3256054

http://www.w3.org/2001/XMLSchema#string